Acadia Healthcare Company, Inc. stock performance trend indicates that the stock price has rallied 20.04% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -15.98% . Looking at the past 52 week period, the stock price is down -20.51% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Acadia Healthcare Company, Inc. has a negative value of -39.28 compared to overall market performance.Acadia Healthcare Company, Inc. is having a Relative Strength Index of 44 which indicates the stock is not yet over sold or over bought based on the technical indicators.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has tumbled 2.48% during the past week and has dropped 2.25% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 2.71%. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has underperformed the index by 3.37% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
For the current week, the company shares have a recommendation consensus of Buy. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.37 points or 0.88% at $41.63 with 1,379,513 shares getting traded. Post opening the session at $42.14, the shares hit an intraday low of $41.56 and an intraday high of $42.2 and the price was in this range throughout the day. The company has a market cap of $3,645 million and the number of outstanding shares has been calculated to be 87,553,024 shares. The 52-week high of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is $65 and the 52-week low is $32.54.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Company shares were Reiterated by Mizuho on Feb 27, 2017 to Buy, Raises Price Target to $ 52 from a previous price target of $45 .Acadia Healthcare Company Inc was Downgraded by Cantor Fitzgerald to Neutral on Jan 27, 2017. Acadia Healthcare Company Inc was Reiterated by KeyBanc Capital Mkts on Jan 11, 2017 to Overweight, Lowers Price Target to $ 52 from a previous price target of $58 .Acadia Healthcare Company Inc was Initiated by Citigroup to Buy on Jan 4, 2017.
Company has reported several Insider transactions to the SEC, on Mar 14, 2017, William Grieco (director) sold 1,000 shares at 42.56 per share price.On Mar 9, 2017, Scott Schwieger (Chief Compliance Officer) sold 1,012 shares at 43.67 per share price.On Mar 9, 2017, Randall P Goldberg (VP of Business Development) sold 914 shares at 43.55 per share price.
Acadia Healthcare Company Inc Last issued its quarterly earnings results on Feb 23, 2017. The company reported $0.59 EPS for the quarter, beating the analyst consensus estimate by $ 0.04. Analyst had a consensus of $0.55. The company had revenue of $702.89 million for the quarter, compared to analysts expectations of $708.66 million. The companys revenue was up 41.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 EPS.
Acadia Healthcare Company, Inc. provides inpatient behavioral health care services. It provides psychiatric and chemical dependency services, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. Acadia Healthcare Company, Inc. is headquartered in Franklin, Tennessee.